A matched pair analysis of oncological outcomes in human papillomavirus‐negative oropharyngeal squamous cell carcinoma: Transoral surgery versus radiotherapy or concurrent chemoradiation
- 29 May 2021
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 43 (10) , 2896-2906
Abstract
Background: With the termination of RTOG 1221, there remains a lacuna regarding the optimal treatment for human papillomavirus (HPV)‐negative oropharyngeal squamous cell carcinoma (OPSCC).Methods: Matched pair analysis with propensity score matching (PSM) between Arm I (transoral surgery [TOS] + risk‐stratified adjuvant treatment) and Arm II (nonsurgical treatment − radiation/chemoradiation) in HPV(−) OPSCC.Results: Unmatched comparison of Arm I (n = 57) and Arm II (n = 89) indicated significantly better overall survival (OS) and disease‐free survival (DFS) for Arm I. PSM by matched pairs (n = 48, 24 each arm) indicated 5‐year OS at 80% and 72.1%, respectively, for Arm I and II (p > 0.05) and corresponding DFS at 65.3% and 33.4% (p > 0.05). Subgroup analysis did not demonstrate statistical difference in outcomes in stage II and III, but stage IV tumors had significantly better outcomes in Arm I than Arm II (4‐year OS: 100% vs. 21%, p = 0.04; DFS: 75% vs. 14.3%, p = 0.04).Conclusions: TOS +/− adjuvant was found to have oncological outcomes at par with nonsurgical modalities in stage I–III OPSCC, whereas a distinct survival advantage was noted in case of stage IV tumors.Keywords
This publication has 25 references indexed in Scilit:
- Utility of up‐front transoral robotic surgery in tailoring adjuvant therapyHead & Neck, 2016
- Detection of active human papilloma virus‐16 in head and neck cancers of Asian North Indian patientsOral Diseases, 2015
- Meta‐analysis on survival of patients treated with transoral surgery versus radiotherapy for early‐stage squamous cell carcinoma of the oropharynxHead & Neck, 2015
- Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal CancerAnnals of Surgical Oncology, 2015
- TransOral endoscopic UltraSonic Surgery (TOUSS): a preliminary report of a novel robotless alternative to TORSEuropean Archives of Oto-Rhino-Laryngology, 2014
- Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal CancersJournal of Clinical Oncology, 2013
- Prevalence and trends of human papillomavirus in oropharyngeal cancer in a predominantly north Indian populationHead & Neck, 2013
- Deintensification Candidate Subgroups in Human Papillomavirus–Related Oropharyngeal Cancer According to Minimal Risk of Distant MetastasisJournal of Clinical Oncology, 2013
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerNew England Journal of Medicine, 2010
- Squamous cell carcinoma of the oropharynxCancer, 2002